EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Sperm DNA fragmentation: how to test, when to test, and what to do with abnormal results—a pragmatic mini-review for clinical practice

Sandro C Esteves iD, Peter Humaidan iD

Human Reproduction · 01.07.2026 · 41 (7) · 1024-1039

DOI: 10.1093/humrep/deag056 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Reproduction, online erschienen am 28.04.2026. Verfasst von Sandro C Esteves und 1 weiteren Autor:innen. Beteiligte Einrichtung: ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, SP, Brazil. Hauptthemen laut MEDLINE: Spermatozoa, DNA Fragmentation, Infertility, Male. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sperm DNA fragmentation (SDF) represents strand breaks that may compromise embryo development, reproductive outcomes, and offspring health, particularly when the oocyte’s repair capacity is limited. This mini-review provides a clinically pragmatic framework addressing how to test, when to test, and whom to test for SDF, translating biological and laboratory insights into actionable andrology practice. The mechanistic basis of SDF is summarized, including the two-step hypothesis linking defective chromatin packaging to oxidative stress, and the combined influence of paternal and maternal aging on the creation and repair of DNA lesions. Contemporary methods for detecting both single- and double-strand breaks (DSBs), as well as DSB-specific platforms, are reviewed with emphasis on assay-specific cut-offs and clinical indications. Management strategies are outlined, prioritizing andrological optimization through lifestyle modification, antioxidant supplementation, treatment of genital tract infection, varicocele repair, and selected hormonal therapy, followed by retesting after one spermatogenic cycle. For persistently high SDF, selective use of testicular sperm for ICSI (Testi-ICSI) and laboratory adjuncts is discussed, supported by evidence of lower miscarriage and higher live-birth rates in defined high-SDF phenotypes. The limitations of the existing observational evidence base—particularly the paucity of phenotype-targeted randomized controlled trials—are highlighted. The review also underscores the value of embedding SDF testing within quality-managed programs and incorporating systematic audits of indications, treatment effects, and ART outcomes. Beyond ART, SDF assessment is positioned within preconception care, recognizing sperm chromatin integrity as a determinant of reproductive and intergenerational health. Future priorities include randomized trials comparing testicular and ejaculated sperm for ICSI in high-SDF cohorts, validation of DSB-specific assays, and longitudinal offspring follow-up to clarify intergenerational effects. This integrative approach promotes precision rather than proliferation of testing, aligning molecular insight with clinical prudence to improve reproductive and generational outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpermatozoaDNA FragmentationInfertility, MaleHumansMaleFemaleOxidative StressSemen AnalysisSperm Injections, Intracytoplasmic

Stichwörter der Autor:innen

DNA fragmentationassisted reproductive technologyinfertilitymalemicrofluidicsoxidative stresspaternal agesemen analysissperm retrievalspermatozoavaricocele

Autor:innen und Institutionen

  • ANDROFERT, Andrology and Human Reproduction Clinic, Campinas, SP, Brazil.
  • Department of Surgery (Division of Urology), Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • University Clinic for Fertility, Skive Regional Hospital, Skive, Denmark.

ORCID-Profile: Sandro C Esteves, Peter Humaidan

Zitieren

APA

Esteves, S. C., & Humaidan, P. (2026). Sperm DNA fragmentation: how to test, when to test, and what to do with abnormal results—a pragmatic mini-review for clinical practice. Human Reproduction, 41(7), 1024-1039. https://doi.org/10.1093/humrep/deag056

Vancouver

Esteves SC, Humaidan P. Sperm DNA fragmentation: how to test, when to test, and what to do with abnormal results—a pragmatic mini-review for clinical practice. Human Reproduction. 2026;41(7):1024-1039. doi:10.1093/humrep/deag056

BibTeX
@article{Esteves2026,
  author = {Esteves, Sandro C and Humaidan, Peter},
  title = {Sperm DNA fragmentation: how to test, when to test, and what to do with abnormal results—a pragmatic mini-review for clinical practice},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {7},
  pages = {1024--1039},
  doi = {10.1093/humrep/deag056}
}
Kostenlos starten →